Pharm Exec7h
Preventing Silos During Product Launches: Q&A with Dan Rizzo
Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...
Wells Fargo Reaffirms Their Hold Rating on Doximity (DOCS)
Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Doximity (DOCS – Research Report) yesterday and set a price target of $55.00.
Analysts Are Neutral on Top Healthcare Stocks: IQVIA Holdings (IQV), Doximity (DOCS)
Analysts fell to the sidelines weighing in on IQVIA Holdings (IQV – Research Report) and Doximity (DOCS – Research Report) with neutral ...